Oncotarget

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 12/26/2017.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

EP300 promotes tumor development and correlates with poor prognosis in esophageal squamous carcinoma

Yanghui Bi, Yanghui Bi, Ling Zhang, Ling Zhang, Heyang Cui, Heyang Cui, Pengzhou Kong, Pengzhou Kong, Ting Yan, Ting Yan, Jiayi Li, Jiayi Li, Zianyi Wang, Zianyi Wang, Caixia Cheng, Caixia Cheng, Bin Song, Bin Song, Bin Yang, Bin Yang, Enwei Xu, Enwei Xu, Jie Yang, Jie Yang, Xiaoling Hu, Xiaoling Hu, Ruyi Shi, Ruyi Shi, Yu Qian, Yu Qian, Fang Wang, Fang Wang, Hongyi Li, Hongyi Li, Zhiwu Jia, Zhiwu Jia, Yanchun Ma, Yanchun Ma, Jian Yang, Jian Yang, Yike Li, Yike Li, Juan Wang, Juan Wang, Yiqian Liu, Yiqian Liu, Yuanfang Zhai, Yuanfang Zhai, Lu Chang, Lu Chang, Yi Wang, Yi Wang, Yingchun Zhang, Yingchun Zhang, Feng Liu, Feng Liu, Haiyan Liu, Haiyan Liu, Yanyan Zhang, Yanyan Zhang, Jing Liu, Jing Liu, Xiaolong Cheng, Xiaolong Cheng, Yongping Cui _ and Yongping Cui _

 

Yanghui Bi1,2,3,*, Ling Zhang1,2,3,4,*, Heyang Cui1,2,3,*, Pengzhou Kong1,2,3,*, Ting Yan1,2,3, Jiayi Li5, Zianyi Wang6, Caixia Cheng1,2,3,7, Bin Song1,2,3,8, Bin Yang1,2,3,9, Enwei Xu1,2,3,10, Jie Yang1,2,3, Xiaoling Hu1,2,3,11, Ruyi Shi1,2,3,12, Yu Qian1,2,3, Fang Wang1,2,3, Hongyi Li1,2,3, Zhiwu Jia1,2,3, Yanchun Ma1,2,3, Jian Yang1,2,3, Yike Li1,2,3, Juan Wang1,2,3, Yiqian Liu1,2,3, Yuanfang Zhai1,2,3, Lu Chang1,2,3, Yi Wang1,2,3, Yingchun Zhang1,2,3, Feng Liu13, Haiyan Liu1,2,3,14, Yanyan Zhang1,2,3,15, Jing Liu1,2,3,15, Xiaolong Cheng1,2,3,16 and Yongping Cui1,2,3

1Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China

2Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China

3Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China

4Department of Pathology, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China

5Anglo-Chinese School (Independent), Singapore

6Taiyuan Lingde Secondary School, Taiyuan, Shanxi 030001, PR China

7Department of Pathology, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China

8Department of Oncology, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China

9Department of General Surgery, Shanxi Cancer Hospital, Taiyuan, Shanxi 030001, PR China

10Department of Pathology, Shanxi Cancer Hospital, Taiyuan, Shanxi 030001, PR China

11Department of Pharmacology, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China

12Department of Cell Biology and Genetics, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China

13Department of Forensic, Shanxi Medical University, Taiyuan, Shanxi, China

14Department of Nuclear Medicine, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China

15Department of General Surgery, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China

16Department of Anatomy, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China

*These authors contributed equally to this work

Correspondence to:

Yongping Cui, email: [email protected]

Keywords: EP300; ESCC; prognosis; angiogenesis; EMT

Received: August 21, 2017     Accepted: October 29, 2017     Epub: December 26, 2017


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23698